… implementing pharmacogenetics (PGx) in clinical practice. The data collected at the time
gave an idea about the progress of this implementation … , PGx clinical implementation may still …

… issues that need to be considered when planning the implementation of pharmacogenomics
into clinical practice… inform the use of pharmacogenomics testing into clinical medicine that …

… issues that need to be considered when planning the implementation of pharmacogenomics
into clinical practice… inform the use of pharmacogenomics testing into clinical medicine that …

… barriers to incorporating pharmacogenomic testing into clinical practice and considers how
these barriers … ; many barriers to clinical implementation of pharmacogenomic testing have …

… adoption of pharmacogenomic testing in clinical practice has … The major barriers in
implementing pharmacogenomic … to use and implement pharmacogenomic data in practice. These …

… The perceived largest barrier to clinical implementation of … as Clinical Pharmacogenetics
Implementation Consortium (… PGx test and how to act in clinical practice [11]. Furthermore, the …

… knowledge required for clinical practice and the need for … issues, combined with the lack of
a unique repository within the EHR for storing these data, present a barrier to their clinical use…

… PGx clinical testing [34]. However, the implementation of EHRs in the SSA clinical setting …
internet connection, and lethargy in the implementation of EHR by health-care stakeholders […

… However, one of the most critical barriers for applying PGx data into clinical practice is
the interpretation of the results of individual genetic variations to determine the selection of …

… barriers to implementing pharmacogenomics in the clinic has … or cost-effectiveness on the
clinical outcome, which would … of pharmacogenomics or find it relevant for clinical practice. …